loadpatents
name:-0.039884805679321
name:-0.043048143386841
name:-0.00048017501831055
Weske; Michael Patent Filings

Weske; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Weske; Michael.The latest application filed is for "screening and treatment methods using igs5 enzymes of the metalloprotease family".

Company Profile
0.22.24
  • Weske; Michael - Burgdorf DE
  • Weske; Michael - Weesp NL
  • Weske, Michael - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
17-beta HSD1 and STS inhibitors
Grant 8,435,973 - Messinger , et al. May 7, 2
2013-05-07
Screening and treatment methods using IGS5 enzymes of the metalloprotease family
Grant 8,389,284 - Deleersnijder , et al. March 5, 2
2013-03-05
Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
Grant 8,273,905 - Moloney , et al. September 25, 2
2012-09-25
Screening and Treatment Methods Using IGS5 Enzymes of the Metalloprotease Family
App 20110262930 - DELEERSNIJDER; Willy ;   et al.
2011-10-27
17.beta.-HSD1 and STS inhibitors
Grant 8,030,298 - Messinger , et al. October 4, 2
2011-10-04
Screening and treatment methods using IGS5 enzymes of the metalloprotease family
Grant 8,012,471 - Deleersnijder , et al. September 6, 2
2011-09-06
17-beta HSD1 and STS Inhibitors
App 20110021480 - Messinger; Josef ;   et al.
2011-01-27
Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
Grant 7,714,150 - Moloney , et al. May 11, 2
2010-05-11
Aminoalkyl-Amidomethyl-Substituted 2-(4-Sulphonylamino)- 3-Hydroxy-3,4-Dihydro-2H-Chroman-6-yl Derivatives
App 20090203686 - Moloney; Brian ;   et al.
2009-08-13
Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease states
Grant 7,534,903 - Sykes , et al. May 19, 2
2009-05-19
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
Grant 7,452,875 - Hoeltje , et al. November 18, 2
2008-11-18
Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
Grant 7,427,611 - Hoeltje , et al. September 23, 2
2008-09-23
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
Grant 7,410,962 - Hoeltje , et al. August 12, 2
2008-08-12
Use of Amidomethyl-Substituted 2-(4-Sulfonylamino)-3-Hydroxy-3,4-Dihydro-2H-Chromen-6-yl-Compounds in the Treatment of Cardiac Arrhythmia and Other Disease States
App 20080113999 - SYKES; David ;   et al.
2008-05-15
Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
Grant 7,368,582 - Sykes , et al. May 6, 2
2008-05-06
Amidomethyl-Substituted 1-(Carboxyalkyl) Cyclopentyl-Carbonylamino-Benzazepine-N-Acetic Acid Compounds, Process and Intermediate Products for Their Preparation and Pharmaceutical Compositions Containing Them
App 20080085889 - Hoeltje; Dagmar ;   et al.
2008-04-10
Novel Human Enzymes of the Metalloprotease Family
App 20080070259 - Deleersnijder; Willy ;   et al.
2008-03-20
Antibody to human enzymes of the metalloprotease family
Grant 7,312,321 - Deleersnijder , et al. December 25, 2
2007-12-25
Amidomethyl-substituted 1-(carboxyalkyl) Cyclopentyl-carbonylamino-benzazepine-n-acetic Acid Compounds, Process And Intermediate Products For Their Preparation And Pharmaceutical Compositions Containing Them
App 20070265244 - Hoeltje; Dagmar ;   et al.
2007-11-15
Method of preparing pharmaceutical compositions
Grant 7,282,325 - Hebebrand , et al. October 16, 2
2007-10-16
Screening and treatment methods using IGS5 enzymes of the metalloprotease family
App 20070224180 - Deleersnijder; Willy ;   et al.
2007-09-27
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
Grant 7,262,184 - Hoeltje , et al. August 28, 2
2007-08-28
Method of treating or inhibiting obesity
Grant 7,238,470 - Hebebrand , et al. July 3, 2
2007-07-03
Novel human enzymes of the metalloprotease family
App 20070148688 - Deleersnijder; Willy ;   et al.
2007-06-28
Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders
Grant 7,232,813 - Ikonomidou , et al. June 19, 2
2007-06-19
Human enzymes of the metalloprotease family
Grant 7,189,525 - Deleersnijder , et al. March 13, 2
2007-03-13
Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
App 20060281732 - Hoeltje; Dagmar ;   et al.
2006-12-14
17SS-HSD1 and STS inhibitors
App 20060281710 - Messinger; Josef ;   et al.
2006-12-14
Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
App 20060252821 - Moloney; Brian ;   et al.
2006-11-09
Novel human enzymes of the metalloprotease family
App 20060205018 - Deleersnijder; Willy ;   et al.
2006-09-14
Human enzymes of the metalloprotease family
Grant 7,083,965 - Deleersnijder , et al. August 1, 2
2006-08-01
Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
App 20050267072 - Ziegler, Dieter ;   et al.
2005-12-01
Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
App 20050267124 - Ziegler, Dieter ;   et al.
2005-12-01
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
Grant 6,946,243 - Hebebrand , et al. September 20, 2
2005-09-20
Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders
App 20050153936 - Ikonomidou, Hrissanthi ;   et al.
2005-07-14
Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chrom- en-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
App 20050148659 - Sykes, David ;   et al.
2005-07-07
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzaze- pine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
App 20050119247 - Hoeltje, Dagmar ;   et al.
2005-06-02
Human enzymes of the metalloprotease family
Grant 6,855,532 - Deleersnijder , et al. February 15, 2
2005-02-15
Novel human enzymes of the metalloprotease family
App 20040224356 - Deleersnijder, Willy ;   et al.
2004-11-11
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
App 20040167213 - Hebebrand, Johannes ;   et al.
2004-08-26
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
App 20040167214 - Hebebrand, Johannes ;   et al.
2004-08-26
Compounds with NEP/MP-inhibitory activity and uses thereof
App 20040162345 - Berger, Claudia ;   et al.
2004-08-19
Human enzymes of the metalloprotease family
App 20030180877 - Deleersnijder, Willy ;   et al.
2003-09-25
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
App 20020022245 - Hebebrand, Johannes ;   et al.
2002-02-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed